Medisafe 1 Technologies Announces the Ex-Dividend Date on April 30 2013, Record Date on May 3 2013 and the Payment Date on May 6 2013
JERUSALEM, January 28, 2013 /PRNewswire/ –
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that
physically prevent unauthorized administration of prescription medications, announced
today that the company intends to issue the one-time special dividend to all existing
shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG
The dates of the dividend are as follows:
Ex-Dividend date for its dividend to its Shareholders on April 30 2013, record date on
May 3 2013 and the payment date on May 6 2013.
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a
drug or medicinal substance by hypodermic needle. Medisafe’s patented technology is a
medical assembly with a locking mechanism that is intended to ensure the substance cannot
be released from the hypodermic needle without positive pre-matching between the substance
and its intended patient.
This letter contains forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of
1934 as amended. All forward-looking statements are inherently uncertain, based on current
expectations and assumptions concerning future events or future performance of Medisafe 1
Technologies Corp., and its technologies. In evaluating such statements, prospective
investors should review carefully various risks and uncertainties identified in this
release, as actual results may differ materially from those indicated. Medisafe 1
Technologies Corp. public filings may be viewed at http://www.sec.gov.
Contact: Jacob Elhadad, CEO +972-524440000 Jacob.email@example.com
SOURCE Medisafe 1 Technologies Corp.